We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+35.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$84.4M
AUM Growth
+$12.4M
Cap. Flow
+$13.1M
Cap. Flow %
15.54%
Top 10 Hldgs %
52.95%
Holding
73
New
10
Increased
3
Reduced
46
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 19.95%
2 Communication Services 14.17%
3 Healthcare 11.22%
4 Technology 6.54%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBB icon
51
iShares Biotechnology ETF
IBB
$9.77B
$238K 0.28%
2,177
-1,088
-33% -$116K
CELG
52
DELISTED
Celgene Corp
CELG
$236K 0.28%
2,554
-333
-12% -$31.6K
NETI
53
DELISTED
Eneti Inc.
NETI
$224K 0.27%
5,234
-326
-6% -$13.9K
BMRN icon
54
BioMarin Pharmaceuticals
BMRN
$12.4B
$220K 0.26%
2,569
-333
-11% -$28.5K
IOVA icon
55
Iovance Biotherapeutics
IOVA
$2.87B
$220K 0.26%
8,988
-1,167
-11% -$17.6K
BCS icon
56
Barclays
BCS
$94.1B
$202K 0.24%
27,124
-11,597
-30% -$91.6K
RESI
57
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$167K 0.2%
13,695
-1,142
-8% -$12.4K
ET icon
58
Energy Transfer Partners
ET
$69.3B
$154K 0.18%
10,954
AM icon
59
Antero Midstream
AM
$10.1B
$126K 0.15%
11,004
DO
60
DELISTED
Diamond Offshore Drilling
DO
$102K 0.12%
11,515
-1,023
-8% -$9.81K
SPPI
61
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$99K 0.12%
11,554
-1,500
-11% -$13.4K
KPTI icon
62
Karyopharm Therapeutics
KPTI
$48M
$77K 0.09%
858
-111
-11% -$8.91K
MTL.PR
63
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$34K 0.04%
38,123
RIGL icon
64
Rigel Pharmaceuticals
RIGL
$750M
$33K 0.04%
1,277
-167
-12% -$3.77K
EQS icon
65
Equus Total Return
EQS
$16.8M
$28K 0.03%
17,286
KA
66
DELISTED
Kineta, Inc. Common Stock
KA
$12K 0.01%
91
-12
-12% -$1.86K
GMO
67
DELISTED
General Moly, Inc.
GMO
$6K 0.01%
17,982
PBYI icon
68
Puma Biotechnology
PBYI
$454M
-6,962
Closed -$270K
SLV icon
69
iShares Silver Trust
SLV
$30.7B
-28,094
Closed -$398K
XOP icon
70
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
-1,665
Closed -$205K
NS
71
DELISTED
NuStar Energy L.P.
NS
-20,520
Closed -$552K
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-3,479
Closed -$586K
EIGI
73
DELISTED
Endurance International Group Holdings, Inc.
EIGI
-20,001
Closed -$145K

Similar funds

Kazazian Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kazazian Asset Management held 73 positions worth $84.4M, up 17% from $72M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Kazazian Asset Management deployed $13.1M of net new capital in Q2 2019, opening 10 new positions and adding to 3 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,091 shares worth $11.5M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $3.66M trimmed.

  • Kazazian Asset Management's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 39,091 shares worth $11.5M.
  • Kazazian Asset Management added most to Baidu in Q2 2019, an estimated $3.56M increase.
  • Kazazian Asset Management's biggest Q2 2019 reduction was Apple, cutting an estimated $3.66M.
  • Kazazian Asset Management fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2019, selling an estimated $586K.
  • Kazazian Asset Management's ten largest holdings make up 53% of its $84.4M portfolio in Q2 2019.
  • Kazazian Asset Management opened 10 new positions and closed 6 in Q2 2019.
  • Kazazian Asset Management's portfolio value rose 17% quarter-over-quarter to $84.4M.

Based on Kazazian Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.